News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Walker Luke Nathaniel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2023 |
4
| Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.89, valued at
$89k
|
|
| 10/04/2022 |
4
| Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 305,000 options to buy
@ $1.08, valued at
$329.4k
|
|
| 03/13/2018 |
4
| Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,315 shares
@ $0
Disposed/sold 2,500 options to buy
@ $35.88, valued at
$89.7k
Disposed/sold 334 options to buy
@ $41.52, valued at
$13.9k
Disposed/sold 1,250 options to buy
@ $28.44, valued at
$35.6k
Disposed/sold 2,500 options to buy
@ $10.44, valued at
$26.1k
Disposed/sold 1,250 options to buy
@ $10.56, valued at
$13.2k
Disposed/sold 5,834 options to buy
@ $21.06, valued at
$122.9k
Disposed/sold 8,334 options to buy
@ $6.9, valued at
$57.5k
Disposed/sold 20,834 options to buy
@ $6.9, valued at
$143.8k
Disposed/sold 35,100 options to buy
@ $4.64, valued at
$162.9k
Disposed/sold 50,000 options to buy
@ $3.99, valued at
$199.5k
|
|
| 02/02/2018 |
4
| Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0 |
|
| 01/16/2018 |
4
| Walker Luke Nathaniel (SVP, Clinical Development) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 637 shares
@ $3.92, valued at
$2.5k
Exercised 1,950 options to buy
@ $0 |
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|